Incidence and Demographic Burden of HPV-Associated Oropharyngeal Head and Neck Cancers in the United States
Brandon A. Mahal(University of Miami), Danielle N. Margalit(Harvard University), Jason Kass(Brigham and Women's Hospital), Paul J. Catalano(Computational Physics (United States)), Jonathan D. Schoenfeld(Brigham and Women's Hospital), Robert I. Haddad(Georgetown University), Roy B. Tishler(Dana-Farber Cancer Institute), Glenn J. Hanna(Dana-Farber Cancer Institute)
Cited by 230
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
|Journal of Clinical Oncology|2007|2.3k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Patients' Expectations about Effects of Chemotherapy for Advanced Cancer
|New England Journal of Medicine|2012|1.1k